<DOC>
	<DOCNO>NCT02446301</DOCNO>
	<brief_summary>This study evaluate relative bioavailability nalbuphine single IM injection Sebacoyl Dinalbuphine Ester ( SDE ) injection Bain® , Nalbuphine HCl IM injection healthy volunteer .</brief_summary>
	<brief_title>A Bioavailability Study Sebacoyl Dinalbuphine Ester IM Injection Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>1 . Subjects must male female adult good health basis medical history , physical examination , electrocardiogram , chest Xray , routine laboratory evaluation . 2 . Vital sign ( 3 minute rest upright position ) within follow range : Ear body temperature 35.037.5°C . Systolic blood pressure , 90140 mm Hg . Diastolic blood pressure , 5090 mm Hg . Pulse rate , 5090 bpm . Fasting blood glucose , &lt; 110 mg/dL . 3 . Within 20 % +20 % ideal body weight . For male subject , body weight must 50 kg female subject , body weight must 45 kg . 4 . Able sign inform consent prior study . 5 . Able communicate well investigator comply requirement study . 1 . Use alcoholcontaining product , prescription medication overthecounter , nonprescription preparation ( include herbal preparation ) within 2 week prior study entry unless deem acceptable Investigator ( except 5 dos ≤ 1000 mg acetaminophen ≤ 400 mg ibuprofen within 2 week period ) . 2 . Alcohol caffeine ingest within 48 hour prior dose . 3 . Significant illness within 2 week prior dose . 4 . Participation clinical investigation within 2 month prior dose longer required local regulation . 5 . Donation loss 500 mL blood within 3 month prior dose . Donation loss 250 mL blood within 2 month prior dose . 6 . Presence cardiovascular disease . 7 . Presence gastrointestinal disease . 8 . Presence asthma lung disease . 9 . Presence liver disease liver injury indicate abnormal liver function profile AST , ALT , gammaGT , Alkaline Phosphatase , Total Bilirubin . ( value AST ALT 3 time upper limit normal range ; item clinically significant abnormality judge investigator ) . 10 . Presence impair renal function indicate abnormal creatinine BUN value abnormal urinary constituent . ( value creatinine BUN beyond range 20 % low limit normal range +20 % upper limit normal range ; item clinically significant abnormality judge investigator ) 11 . Presence neurological disease . 12 . Presence psychiatric disease . 13 . Subject positive HIV immunology test . 14 . A known hypersensitivity nalbuphine analog . 15 . History drug alcohol abuse within 12 month prior dose . 16 . Permanent confinement institution . 17 . Pregnant lactating woman . 18 . Individuals judge investigator pharmacokineticist undesirable subject reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Nalbuphine</keyword>
	<keyword>SDE</keyword>
	<keyword>dinalbuphine</keyword>
	<keyword>SDN</keyword>
	<keyword>pain</keyword>
	<keyword>LT1001</keyword>
</DOC>